http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2006244080-C1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eb141b396e502bfce986c491d722e401 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-02 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-18 |
filingDate | 2006-05-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2012-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_afabfe655bb17d586ca626a65a863cf9 |
publicationDate | 2012-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | AU-2006244080-C1 |
titleOfInvention | Use of peptides derived from the growth factor AMP-18 for the treatment of mucositis |
abstract | Methods and compositions of AMP- 18 derived peptides enablingly demonstrate that AMP-18 derived peptide compositions surprisingly reduce mucositis in mammals. Methods and peptide compositions treat mucositis, delays the onset or duration of mucositis, including cancer therapy-induced mucositis are disclosed. AMP 77-97 peptide derived from human AMP-18 protein alleviates cancer therapy-induced mucositis. |
priorityDate | 2005-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 355.